首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Determination of residual 4-nitrobenzaldehyde in chloramphenicol and its pharmaceutical formulation by HPLC with UV/Vis detection after derivatization with 3-nitrophenylhydrazine
【24h】

Determination of residual 4-nitrobenzaldehyde in chloramphenicol and its pharmaceutical formulation by HPLC with UV/Vis detection after derivatization with 3-nitrophenylhydrazine

机译:用3-硝基苯基肼衍生化衍生化衍生化后HPLC中氯霉素中残留4-硝基苯醛及其药物制剂

获取原文
获取原文并翻译 | 示例
           

摘要

4-Nitrobenzaldehyde is the synthetic raw material and an important photodegradation product of chloramphenicol. With a structural "alert" of human genotoxic potential and reported mutagenicity, this compound should be controlled in drug substances as a potential genotoxic impurity. However, current analysis methods require complex pre-treatment processes and/or lack sufficient specificity and sensitivity. Nitrophenylhydrazine is a common carbonyl derivatization reagent used to determine the residual aromatic aldehydes in drug samples. In the present study, we report an unexpected advantage of 3-nitrophenylhydrazine hydrochloride as a derivatization reagent in the derivatization high-performance liquid chromatography-ultraviolet detection method to determine 4-nitrobenzaldehyde in chloramphenicol samples. Compared with other nitro-substituted phenylhydrazines, 3-nitrophenylhydrazine hydrochloride can minimize drug matrix and derivatization reagent interferences, since the maximum absorption wavelength of its derivative is significantly red-shifted to 397 nm. The derivatization conditions have been optimized in terms of reaction efficiency, including reaction temperature, time, and diluting solvent, through a design of experiments. As a result, after reaction with 500 mu g mL(-1) of 3-nitrophenylhydrazine hydrochloride in acetonitrile-water (70:30, v/v) at 60 degrees C for 30 min, the developed HPLC method could be used to determine 4-nitrobenzaldehyde with a limit of detection of 0.009 mu g mL(-1). The method was then validated and applied for the determination of residual 4-nitrobenzaldehyde in chloramphenicol and its eye-drop samples. (C) 2018 Published by Elsevier B.V.
机译:4-硝基苯醛是合成原料和氯霉素的重要光降解产物。对于人类遗传毒性潜力和报告致突变性的结构“警报”,该化合物应以药物物质控制为潜在的遗传毒性杂质。然而,目前的分析方法需要复杂的预处理过程和/或缺乏足够的特异性和敏感性。硝基苯肼是用于测定药物样品中残留芳族醛的常见羰基衍生化试剂。在本研究中,我们在衍生化高性能液相色谱 - 紫外检测方法中报告了3-硝基苯基肼的意外优点,作为衍生化试剂,以确定氯霉素样品中4-硝基苯醛。与其他硝基取代的苯肼相比,3-硝基苯基肼可以最小化药物基质和衍生物试剂干扰,因为其衍生物的最大吸收波长显着红移至397nm。通过设计实验,在反应效率方面已经在反应效率,包括反应温度,时间和稀释溶剂方面进行了优化。结果,在60℃下与乙腈 - 水(70:30,v / v)中的3-硝基苯基肼的3-硝基苯基肼(-1)反应30分钟后,可以使用开发的HPLC方法来确定4-硝基苯醛,检测限为0.009μgmm(-1)。然后验证该方法并施加用于测定氯霉素中残留的4-硝基苯甲醛及其滴眼样品。 (c)2018由elestvier b.v出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号